Skip to main content
Clinical Trials/CTRI/2018/08/015555
CTRI/2018/08/015555
Completed
未知

A clinical assessment to evaluate the effect of two different combinations of anti-hypertensive drugs (Telmisartan 40 mg plus Amlodipine 5 mg and Telmisartan 40 mg plus Cilnidipine 10 mg among Subjects with uncontrolled hypertension in India â?? A prospective, randomized, investigator initiated study.

Current Medical Concepts Pvt Ltd0 sites93 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Current Medical Concepts Pvt Ltd
Enrollment
93
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 20, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Current Medical Concepts Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • a) Adults greater than or equal to 18 years and
  • less than or equal to 70 years old both male
  • and female.
  • b) Subjects with uncontrolled BP who are on
  • monotherapy.
  • c) Systolic Blood Pressure (SBP) \>130 mmHg and
  • Diastolic Blood Pressure (DBP) \> 80
  • mmHg based on three consecutive blood
  • pressure readings
  • d) Any stage of Hypertension.

Exclusion Criteria

  • a) Women of child bearing potential
  • b) History of Myocardial infarction, Acute
  • stroke, Acute kidney injury in the last 3
  • c) Subjects with history of congestive heart
  • d) Subjects with advanced CKD with Serum
  • Creatinine value \> 2\.5 mg/dL.
  • e) History of allergy to calcium channel
  • blockers and angiotensin receptor blockers
  • f) Inability to give informed consent
  • g) Subject with hypertensive crisis (Seated BP

Outcomes

Primary Outcomes

Not specified

Similar Trials